Evidence map›Paper›PMID 32476175›Full record

ArticleThe International journal of eating disorders2020

The impact of the COVID-19 pandemic on eating disorder risk and symptoms.

Rachel F Rodgers, Caterina Lombardo, Silvia Cerolini, Debra L Franko, Mika Omori, Matthew Fuller-Tyszkiewicz, Jake Linardon, Philippe Courtet, Sebastien Guillaume

Open access · bronzeAbstract read
In one paragraph

Article in The International journal of eating disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 234 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
234citing papers in PubMed, 10 pooled it
46.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

234 citing papers in PubMed, 10 syntheses or guidelines pooled it, 659 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Effects of COVID-19 lockdown on eating disorders and obesity: A systematic review and meta-analysis.European eating disorders review : the journal of the Eating Disorders Association · 2021
    Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. The impact of COVID-19 on body-dissatisfied female university students.The International journal of eating disorders · 2021
    Trial
  16. Eating behaviour and symptom trajectories in patients with a history of binge eating disorder during COVID-19 pandemic.European eating disorders review : the journal of the Eating Disorders Association · 2021
    Trial
  17. Trial
  18. Review
  19. Impact of COVID-19 Lockdown on Psychopathology at the Onset of Eating Disorders.European eating disorders review : the journal of the Eating Disorders Association · 2026
    Article
  20. Review

174 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 5 countries.

Rachel F RodgersAPPEAR, Department of Applied Psychology, Northeastern University, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-2582-4220
Caterina LombardoDepartment of Psychology, Sapienza University of Rome, Rome, Italy.
Silvia CeroliniDepartment of Psychology, Sapienza University of Rome, Rome, Italy.
Debra L FrankoAPPEAR, Department of Applied Psychology, Northeastern University, Boston, Massachusetts, USA.
Mika OmoriDepartment of Psychology, Ochanomizu University, Tokyo, Japan.
Matthew Fuller-TyszkiewiczSchool of Psychology, Deakin University, Melbourne, Victoria, Australia.
Jake LinardonSchool of Psychology, Deakin University, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0003-4475-7139
Philippe CourtetDepartment of Psychiatric Emergency & Acute Care , Lapeyronie Hospital, CHRU Montpellier, Montpellier, France.
Sebastien GuillaumeDepartment of Psychiatric Emergency & Acute Care , Lapeyronie Hospital, CHRU Montpellier, Montpellier, France.ORCID https://orcid.org/0000-0002-6769-9982
Deakin University · AUHôpital Lapeyronie · FRNortheastern University · USSapienza University of Rome · ITOchanomizu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current COVID-19 pandemic has created a global context likely to increase eating disorder (ED) risk and symptoms, decrease factors that protect against EDs, and exacerbate barriers to care. Three pathways exist by which this pandemic may exacerbate ED risk. One, the disruptions to daily routines and constraints to outdoor activities may increase weight and shape concerns, and negatively impact eating, exercise, and sleeping patterns, which may in turn increase ED risk and symptoms. Relatedly, the pandemic and accompanying social restrictions may deprive individuals of social support and adaptive coping strategies, thereby potentially elevating ED risk and symptoms by removing protective factors. Two, increased exposure to ED-specific or anxiety-provoking media, as well as increased reliance on video conferencing, may increase ED risk and symptoms. Three, fears of contagion may increase ED symptoms specifically related to health concerns, or by the pursuit of restrictive diets focused on increasing immunity. In addition, elevated rates of stress and negative affect due to the pandemic and social isolation may also contribute to increasing risk. Evaluating and assessing these factors are key to better understanding the impact of the pandemic on ED risk and recovery and to inform resource dissemination and targets.

Indexed as

Adaptation, PsychologicalBetacoronavirusCoronavirus InfectionsCOVID-19ExerciseFearFeeding and Eating DisordersFeeding BehaviorFemaleHumansMalePandemicsPneumonia, ViralQuarantineRisk FactorsSARS-CoV-2access to carebody imageCOVID-19eating disordersmediarisk and protective factors

Identifiers

PMID32476175
PMCPMC7300468
OpenAlexW3030981292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.